(CELH) Celsius Holdings - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US15118V2079
CELH: Energy, Drinks, Hydration, Powders, Beverages
Celsius Holdings, Inc. (NASDAQ: CELH) is a leading developer and distributor of functional energy drinks, operating across the United States, North America, Europe, the Asia Pacific, and other international markets. The company’s product portfolio includes CELSIUS, a lifestyle and energy drink; CELSIUS Originals and Vibe, which are functional energy drinks available in carbonated and non-carbonated forms; CELSIUS ESSENTIALS, a functional energy drink with added aminos; CELSIUS On-the-Go Powder, a convenient powder format; and CELSIUS Hydration, a zero-sugar hydration line with electrolytes. The company also offers ready-to-drink products. Its distribution network spans direct-to-store delivery, independent distributors, supermarkets, convenience stores, drug stores, nutritional stores, food service providers, mass merchants, natural food stores, fitness centers, vitamin specialty stores, club stores, gyms, and e-commerce platforms. Formerly known as Vector Ventures, Inc., the company rebranded as Celsius Holdings, Inc. in January 2007 and is headquartered in Boca Raton, Florida, with a strong focus on innovation and health-conscious consumers.
Over the next three months, CELH is expected to show continued upward momentum, supported by strong revenue growth and expanding distribution channels. Technically, the stock is trading above its 20-day and 50-day SMAs, with the 20-day SMA crossing above the 50-day SMA, indicating short-term bullish momentum. The 200-day SMA at 32.88 provides a key support level. With an ATR of 2.18, price fluctuations are expected to remain moderate. Fundamentally, the company’s high P/E ratio of 80.20 reflects strong earnings expectations, while the forward P/E of 43.29 suggests potential normalization in growth expectations. The P/S ratio of 6.86 indicates a premium valuation relative to its peers. Based on these factors, the stock is projected to trade in a range of $33.50 to $42.00 over the next quarter, with a potential upside target of $40.50 and support at $35.20.
Additional Sources for CELH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CELH Stock Overview
Market Cap in USD | 9,302m |
Sector | Consumer Defensive |
Industry | Beverages - Non-Alcoholic |
GiC Sub-Industry | Soft Drinks & Non-alcoholic Beverages |
IPO / Inception | 2007-02-02 |
CELH Stock Ratings
Growth Rating | 56.8 |
Fundamental | 61.0 |
Dividend Rating | 0.0 |
Rel. Strength | -55.9 |
Analysts | 4.1/5 |
Fair Price Momentum | 45.41 USD |
Fair Price DCF | 18.28 USD |
CELH Dividends
No Dividends PaidCELH Growth Ratios
Growth Correlation 3m | 91.4% |
Growth Correlation 12m | -71.5% |
Growth Correlation 5y | 76% |
CAGR 5y | 86.17% |
CAGR/Max DD 5y | 1.11 |
Sharpe Ratio 12m | -2.29 |
Alpha | -59.50 |
Beta | 0.567 |
Volatility | 63.21% |
Current Volume | 4446.9k |
Average Volume 20d | 6443.7k |
As of May 01, 2025, the stock is trading at USD 34.96 with a total of 4,446,896 shares traded.
Over the past week, the price has changed by -6.20%, over one month by -1.85%, over three months by +39.95% and over the past year by -50.95%.
Yes, based on ValueRay Fundamental Analyses, Celsius Holdings (NASDAQ:CELH) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 61.03 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CELH as of May 2025 is 45.41. This means that CELH is currently undervalued and has a potential upside of +29.89% (Margin of Safety).
Celsius Holdings has received a consensus analysts rating of 4.10. Therefor, it is recommend to buy CELH.
- Strong Buy: 8
- Buy: 8
- Hold: 4
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, CELH Celsius Holdings will be worth about 50.7 in May 2026. The stock is currently trading at 34.96. This means that the stock has a potential upside of +44.91%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 40.8 | 16.6% |
Analysts Target Price | 40.2 | 14.9% |
ValueRay Target Price | 50.7 | 44.9% |